New ventilatory strategies in intensive care

Acta Anaesthesiologica Scandinavica, Supplement

Volumn 41, Issue 111, 1997, Pages 69-74

  Lachmann, B ^a   Rajan, N G ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROCARBON; LUNG SURFACTANT; RESPIRATORY TRACT AGENT;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL; ARTICLE; ARTIFICIAL VENTILATION; DRUG EFFECT; HUMAN; INTENSIVE CARE; LUNG; LUNG ALVEOLUS; LUNG GAS EXCHANGE; METHODOLOGY; OXYGEN THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSURE; TIDAL VOLUME; CONFERENCE PAPER; GAS EXCHANGE; LUNG FUNCTION; LUNG INJURY; OXYGENATION; PRIORITY JOURNAL;

ANIMALS; FLUOROCARBONS; HUMANS; INTENSIVE CARE; LUNG; OXYGEN INHALATION THERAPY; PRESSURE; PULMONARY ALVEOLI; PULMONARY GAS EXCHANGE; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY SYSTEM AGENTS; TIDAL VOLUME;

EID: 0031306105     PISSN: 05152720     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Houmes RJ, Bos JAH, Lachmann B. Effects of different ventilator settings on lung mechanics: with special reference to the surfactant system. Appl Cardiopulm Pathophysiol 1994: 5: 117-127.
2. Lachmann B. Open up the lung and keep the lung open. Intensive Care Med 1992: 118: 319-321.
3. Verbrugge S, Gommers D, Lachmann B. Liquid ventilation as an alternative ventilatory support. Current Opinion Anaesthesiol 1995: 8: 551-556.
4. Gommers D, Lachmann B. Surfactant therapy in the adult patient. Current Opinion Crit Care 1995: 1: 57-61.
5. Mead J, Takashima T, Leith D. Stress distribution in lungs: a model of pulmonary elasticity. J Appl Physiol 1970: 28: 596-608.
6. Haendly B, Lachmann B, Schulz H, Jonson B. Der Einflußerschiedener Beatmungsmuster auf Lungenmechanik ung Gasaustausch bei Patienten während Respiratorbehandlung. Kongreßbericht Anaesthesie 1978: 1: 665-678.
7. Lachmann B, Danzmann E, Haendly B, Jonson B. Ventilator settings and gas exchange in respiratory distress syndrome. In: Prakash O (ed) Applied physiology in clinical respiratory care. Nijhoff, The Hague, 1982: 41-176.
8. Kesecioglu J, Tibboel D, Lachmann B. Advantages and rationale for pressure controlled ventilation. In: Vincent JL (ed) Yearbook of intensive care and emergency medicine. Berlin, Heidelberg, New York, 1994: 524-533.
9. Amato MBP, Barbas CSV, Medeiros DM, Schettino GPP, Filho GL, Kairalla RA et al. Beneficial effects of the "open lung approach" with low distending pressures in acute respiratory distress syndrome. Am J Respir Crit Care Med 1995: 152: 1835-1846.
10. Barbas CSV, Amato MBP, de Carvalho CRR. Outcome in intensive care depends on ventilator settings. App Cardiopulm PathoPhysiol 1996: 6: 191-199.
11. Von Neergaard K. Neue Auffassungen über einen Grundbegriff der Atemmechanik; Die Retraktionskraft der Lunge, abhängig von der Oberflächenspannung in den Alveolen. Z Ges Exp Med 1929: 66: 373-394.
12. Fuhrman BP, Paczan PR, DeFrancis M. Perfluorocarbon-associated gas exchange. Crit Care Med 1991: 19: 712-722.
13. Tütüncu AS, Faithfull NS, Lachmann B. Intratracheal perfluorocarbon administration combined with artificial ventilation in experimental respiratory distress syndrome: dose dependent improvement of gas exchange. Crit Care Med 1993: 21: 962-969.
14. Tütüncu AS, Faithfull NS, Lachmann B. Comparison of ventilatory support with intratracheal perfluorocarbon administration and conventional mechanical ventilation in animals with acute respiratory failure. Am Rev Respir Dis 1993: 148: 785-792.
15. Tütüncu AS, Faithfull NS, Lachmann B. Intratracheal perfluorocarbon administration as an aid in the ventilatory management of respiratory distress syndrome. Anesthesiology 1993: 79: 1083-1093.
16. Houmes RJM, Verbrugge S, Hendrik ER, Lachmann B. Hemodynamic effects of partial liquid ventilation with perfluorocarbon in acute lung injury. Intensive Care Med 1995: 21: 966-972.
17. Lachmann B, Verbrugge S. Liquid ventilation. Current Opinion Crit Care 1996: In press.
18. Leach CL, Greenspan JS, Rubenstein SD et al. Partial liquid ventilation with Perflubron (LiquiVent™): a pilot safety and efficacy study in premature newborns with severe RDS who have failed conventional therapy and exogenous surfactant. In: Lucey JF (ed) ROSS Special Conference, Hot Topics '94 in Neonatology, Washington DC, 1994: 161.
19. Hirschl RB, Pranikoff T, Gauger P, Schreiner RJ, Dechert R, Bartlett RH. Liquid ventilation in adults, children, and full-term neonates. Lancet 1995: 346: 1201-1202.
20. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993: 328: 861-868.
21. Lachmann B, Eijking EP, So KL, Gommers D. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Intensive Care Med 1994. 20: 6-11.
22. Pinkerton KE, Lewis J, Mulder AM, Ikegami M, Jobe AH. Surfactant treatment effects on alveolar type II cell morphology in rabbit lungs. J Appl Physiol 1993: 74: 1240-1247.
23. Gommers D, Lachmann B. Surfactant therapy: does it have a role in adults? Clin Intensive Care 1993: 4: 284-295.
24. Gregory TJ, Steinberg KP, Spragg R et al. Bovine Surfactant Therapy for Patients with Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 1997: 155: 1309-1315.
25. Seeger W, Grube C, Günther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Resp J 1993: 6: 971-977.
26. Anzueto A, Baughman R, Guntupalli K et al. An international, randomized, placebo-controlled trial evaluating the safety and efficacy of aerosolized surfactant in patients with sepsis-induced ARDS. Am J Respir Crit Care Med 1994: 149: A567 (Abst).
27. Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 1993: 148: 569-577.
28. Asbaugh DG, Bingelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967: 2: 319-323.